Key role of mast cells and their major secretory products in inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

607

HTML

5950

Figures (1-3)

193

Tables (1-1)

170

Sum=6920

Feb 1, 2004 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 1, 2004; 10(3): 309-318
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.309

Figure 1 Hypothesis of self-amplification mechanism of mast cell degranulation in gut.

Figure 2 Association of mast cells with IBD therapies.

Figure 3 Balance between “pro-inflammatory” and “anti-in-flammatory” mast cell mediators in IBD.

Citation: He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004; 10(3): 309-318
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/309.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i3.309